BR0102604A - Solução de sal monossódico da n-[o-(p-pivaloiloxibenzenossul-fonilamino) benzoil] glicina tetrahidratado e produto de droga do mesmo - Google Patents
Solução de sal monossódico da n-[o-(p-pivaloiloxibenzenossul-fonilamino) benzoil] glicina tetrahidratado e produto de droga do mesmoInfo
- Publication number
- BR0102604A BR0102604A BR0102604-6A BR0102604A BR0102604A BR 0102604 A BR0102604 A BR 0102604A BR 0102604 A BR0102604 A BR 0102604A BR 0102604 A BR0102604 A BR 0102604A
- Authority
- BR
- Brazil
- Prior art keywords
- tetrahydrate
- benzoyl
- glycine
- drug product
- monosodium salt
- Prior art date
Links
- -1 p-pivaloyloxybenzenesulphonylamino Chemical group 0.000 title abstract 3
- UXNRIGOFQRMROV-UHFFFAOYSA-N 2-aminoacetic acid;tetrahydrate Chemical compound O.O.O.O.NCC(O)=O UXNRIGOFQRMROV-UHFFFAOYSA-N 0.000 title abstract 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 title abstract 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 title abstract 2
- 229940126534 drug product Drugs 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 3
- 239000012266 salt solution Substances 0.000 abstract 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 239000003002 pH adjusting agent Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 239000001488 sodium phosphate Substances 0.000 abstract 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 abstract 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 abstract 1
- 235000019801 trisodium phosphate Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000195853 | 2000-06-29 | ||
JP2000195852 | 2000-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
BR0102604A true BR0102604A (pt) | 2002-02-13 |
BR0102604B1 BR0102604B1 (pt) | 2012-06-26 |
Family
ID=26594951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0102604-6A BR0102604B1 (pt) | 2000-06-29 | 2001-06-28 | composição farmacêutica compreendendo sal monossódico da n-[o- (p-pivaloiloxibenzenossulfonilamino) benzoil] glicina tetrahidratado e uso da mesma. |
Country Status (19)
Country | Link |
---|---|
US (1) | US6552082B2 (pt) |
EP (1) | EP1166773B1 (pt) |
KR (1) | KR100725076B1 (pt) |
CN (1) | CN1263736C (pt) |
AT (1) | ATE259218T1 (pt) |
AU (1) | AU782838B2 (pt) |
BR (1) | BR0102604B1 (pt) |
CA (1) | CA2351273C (pt) |
DE (1) | DE60101979T2 (pt) |
DK (1) | DK1166773T3 (pt) |
ES (1) | ES2215856T3 (pt) |
HU (1) | HUP0102699A2 (pt) |
MX (1) | MXPA01006698A (pt) |
NO (1) | NO330296B1 (pt) |
NZ (1) | NZ512486A (pt) |
PT (1) | PT1166773E (pt) |
RU (1) | RU2272623C2 (pt) |
TR (1) | TR200400585T4 (pt) |
TW (1) | TWI246925B (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002224526A1 (en) * | 2000-07-24 | 2002-02-05 | Ono Pharmaceutical Co. Ltd. | Freeze-dried preparation of n-(o-(p-pivaloyloxybenzenesulfonylamino)benzoyl)glycine monosodium salt tetrahydrate and process for producing the same |
DE60219619T2 (de) * | 2001-05-17 | 2007-12-27 | Ono Pharmaceutical Co. Ltd. | Mittel zur behandlung von myelopathie |
BRPI0415001A (pt) * | 2003-10-03 | 2006-11-07 | Ono Pharmaceutical Co | droga contendo ácido (2r)-2-propiloctanóico como o ingrediente ativo |
US8277845B2 (en) | 2007-12-04 | 2012-10-02 | Remedy Pharmaceuticals, Inc. | Formulations and methods for lyophilization and lyophilates provided thereby |
KR101247137B1 (ko) * | 2011-03-23 | 2013-04-01 | 주식회사 엠씨켐 | N-[o-(p-피발로일옥시벤젠술포닐아미노)벤조일]글리신의 신규 제조 방법 및 그 모노나트륨염ㆍ4 수화물의 동결 건조 제제의 제조 방법 |
KR101366706B1 (ko) | 2012-12-06 | 2014-02-24 | 상명대학교서울산학협력단 | N-[o-(p-피발로일옥시벤젠술포닐아미노)벤조일]글리신의 신규 제조 방법 및 그 모노나트륨염ㆍ4 수화물의 동결 건조 제제의 제조 방법 |
CN104107172B (zh) * | 2013-04-18 | 2017-11-28 | 上海汇伦生命科技有限公司 | 西维来司钠注射用冻干粉的制备方法 |
CN114681435A (zh) | 2020-12-31 | 2022-07-01 | 上海汇伦生物科技有限公司 | 吸入用药物组合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0143565B1 (ko) | 1988-06-13 | 1998-07-15 | 사노 가즈오 | 피발산의 p-치환된 페닐 에스테르 유도체, 그의 제조 방법 및 이를 포함하는 조성물. |
JPH0320253A (ja) | 1988-06-13 | 1991-01-29 | Ono Pharmaceut Co Ltd | ピバル酸 p―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤 |
IT1242642B (it) * | 1990-04-17 | 1994-05-16 | Alfa Wassermann Spa | Formulazioni iniettabili contenenti naproxen sale sodico. |
JP3020253B2 (ja) | 1990-05-02 | 2000-03-15 | 松下電工株式会社 | 配線器具の取付枠への取付構造 |
EP0539223A1 (en) | 1991-10-25 | 1993-04-28 | Ono Pharmaceutical Co., Ltd. | Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase |
JPH05194366A (ja) | 1991-10-25 | 1993-08-03 | Ono Pharmaceut Co Ltd | グリシン誘導体・モノナトリウム塩・4水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法 |
JP3193597B2 (ja) | 1995-07-28 | 2001-07-30 | 小野薬品工業株式会社 | グリシン誘導体の製造方法 |
AU5528299A (en) | 1998-09-15 | 2000-04-03 | Naeja Pharmaceutical Inc. | Combined therapy for treatment of inflammation using elastase inhibitor(s) and antibacterial agent(s) |
CN1387436A (zh) * | 1999-09-06 | 2002-12-25 | 小野药品工业株式会社 | 眼部疾病的预防和治疗性药物 |
-
2001
- 2001-06-18 US US09/882,335 patent/US6552082B2/en not_active Expired - Fee Related
- 2001-06-19 NZ NZ512486A patent/NZ512486A/en not_active IP Right Cessation
- 2001-06-21 TW TW090115094A patent/TWI246925B/zh not_active IP Right Cessation
- 2001-06-22 CA CA2351273A patent/CA2351273C/en not_active Expired - Fee Related
- 2001-06-27 TR TR2004/00585T patent/TR200400585T4/xx unknown
- 2001-06-27 ES ES01305556T patent/ES2215856T3/es not_active Expired - Lifetime
- 2001-06-27 AT AT01305556T patent/ATE259218T1/de active
- 2001-06-27 EP EP01305556A patent/EP1166773B1/en not_active Expired - Lifetime
- 2001-06-27 DK DK01305556T patent/DK1166773T3/da active
- 2001-06-27 PT PT01305556T patent/PT1166773E/pt unknown
- 2001-06-27 NO NO20013223A patent/NO330296B1/no not_active IP Right Cessation
- 2001-06-27 AU AU54092/01A patent/AU782838B2/en not_active Ceased
- 2001-06-27 KR KR1020010036853A patent/KR100725076B1/ko active IP Right Grant
- 2001-06-27 DE DE60101979T patent/DE60101979T2/de not_active Expired - Lifetime
- 2001-06-28 RU RU2001118162/15A patent/RU2272623C2/ru not_active IP Right Cessation
- 2001-06-28 MX MXPA01006698A patent/MXPA01006698A/es active IP Right Grant
- 2001-06-28 HU HU0102699A patent/HUP0102699A2/hu unknown
- 2001-06-28 BR BRPI0102604-6A patent/BR0102604B1/pt not_active IP Right Cessation
- 2001-06-29 CN CNB011254688A patent/CN1263736C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1341591A (zh) | 2002-03-27 |
EP1166773B1 (en) | 2004-02-11 |
CA2351273C (en) | 2010-09-07 |
US6552082B2 (en) | 2003-04-22 |
US20020022738A1 (en) | 2002-02-21 |
MXPA01006698A (es) | 2004-07-30 |
ATE259218T1 (de) | 2004-02-15 |
NO20013223L (no) | 2001-12-31 |
NO330296B1 (no) | 2011-03-21 |
RU2272623C2 (ru) | 2006-03-27 |
AU5409201A (en) | 2002-03-28 |
PT1166773E (pt) | 2004-05-31 |
KR100725076B1 (ko) | 2007-06-08 |
CN1263736C (zh) | 2006-07-12 |
TWI246925B (en) | 2006-01-11 |
TR200400585T4 (tr) | 2004-04-21 |
CA2351273A1 (en) | 2001-12-29 |
KR20020002242A (ko) | 2002-01-09 |
EP1166773A1 (en) | 2002-01-02 |
DE60101979T2 (de) | 2005-01-05 |
ES2215856T3 (es) | 2004-10-16 |
HUP0102699A2 (en) | 2002-06-29 |
NO20013223D0 (no) | 2001-06-27 |
DE60101979D1 (de) | 2004-03-18 |
AU782838B2 (en) | 2005-09-01 |
HU0102699D0 (en) | 2001-08-28 |
BR0102604B1 (pt) | 2012-06-26 |
NZ512486A (en) | 2001-12-21 |
DK1166773T3 (da) | 2004-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9810658A (pt) | Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna. | |
CY1112274T1 (el) | Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν | |
TR199903191T2 (xx) | Vorikonazol i�eren ila� form�lasyonlar�. | |
CY1109912T1 (el) | 3-[(2z)-[1-(3,4-διμεθυλοφαινυλο)-1,5-διυδρο-3-μεθυλο-5-οξο-4η-πυραζολο-4-υλιδενο]υδραζινο-2’-υδροξυ-[1,1’-διφαινυλο]-3-καρβοξυλικο οξυ δι-(μονοαιθανολαμινικο) | |
AU2001289438A1 (en) | Pharmaceutical semi-solid composition of isotretinoin | |
BR9902086A (pt) | Formulações farmacêuticas. | |
BR0007472A (pt) | Agente contendo paramilonas, seco por congelação, sua produção e utilização | |
IS2148B (is) | (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem COX-2 hindrar | |
AU5242000A (en) | Nematicidal trifluorobutenes | |
HUP0000564A2 (hu) | Olajos szuszpenzió alakú gyógyászati készítmények | |
IL119989A0 (en) | Pharmaceutical compositions for oral treatment of multiple sclerosis | |
MXPA03006224A (es) | Inhibidores de cruzipaina y otras proteasas de cisteina. | |
BR0102604A (pt) | Solução de sal monossódico da n-[o-(p-pivaloiloxibenzenossul-fonilamino) benzoil] glicina tetrahidratado e produto de droga do mesmo | |
TR199902703T2 (xx) | Proteaz inhibit�rleri. | |
NZ505821A (en) | Pharmaceutical compositions of uridine triphosphate | |
IT1293778B1 (it) | 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli | |
PL346764A1 (en) | New oral formulation for 5-ht4 | |
DE69928279D1 (de) | Lungensurfactant zubereitungen enthaltendes behandlungset | |
DE60106040D1 (de) | Verfahren zur herstellung von dinatrium-2,2'-dithiobis(ethansulfonat) | |
NO993407L (no) | Fremstilling av proteinpreparater med nedsatt aggregatinnhold | |
WO2002056840A3 (de) | Kosmetisches und/oder pharmazeutisches mittel acylierte aminosaüre enthaltend. | |
HU9600758D0 (en) | Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption | |
PT896821E (pt) | Uma nova composicao farmaceutica para inalacao que contem cr 2039 (andolast) | |
NO306395B1 (no) | Tilidindihydrogenortofosfat, fremgangsmaate for dets fremstilling og farmasöytiske preparater inneholdende forbindelsen samt anvendelser derav | |
ATE222758T1 (de) | S-alkylisothiouronium-derivate enthaltende pharmazeutische zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA: INT. CL. A61K 31/22, A61K 9/19, A61K 47/02, A61K 9/08, A61P11/00 Ipc: A61K 31/22 (2010.01), A61K 9/19 (2010.01), A61K 47 |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B09X | Republication of the decision to grant [chapter 9.1.3 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/06/2012, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AS 12A, 13A E 14A ANUIDADES. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |